Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Anna Solberg, Lena Holmdahl, Peter Falk, Roger Willén, Ingrid Palmgren & Marie-Louise Ivarsson. (2009) Progress of tissue injury in appendicitis involves the serine proteases uPA and PAI-1. Scandinavian Journal of Gastroenterology 44:5, pages 579-584.
Read now
Read now
Helge L. Waldum. (2008) August issue of Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 43:8, pages 899-901.
Read now
Read now
Kjetil Søreide. (2008) Bacterial genotoxins, gene methylation, and RNA interference: Pointing to colorectal cancer as an infectious disease?. Scandinavian Journal of Gastroenterology 43:12, pages 1529-1533.
Read now
Read now
Articles from other publishers (17)
Min Bai, Linna Zhao, Mengya Liu, Runfa Li, Yuping Yang, Yugui Zhang, Xiaomei Yuan, Yarong Li, Yongqiang Duan, Yaorong An & Yingxia Cheng. (2024) Deciphering the function of Xiangsha-Liujunzi-Tang in enhancing duodenal mucosal barrier by inhibiting MC/Tryptase/PAR-2 signaling pathway in functional dyspepsia rats. Journal of Ethnopharmacology 319, pages 116715.
Crossref
Crossref
Tingting Cai, Xiang Wang, Bangjie Li, Fei Xiong, Hao Wu & Xinghao Yang. (2021) Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringin. Phytomedicine 86, pages 153527.
Crossref
Crossref
Kjetil SøreideMarcus RoalsøJan Rune Aunan. (2020) Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis. Journal of Pancreatic Cancer 6:1, pages 12-20.
Crossref
Crossref
Elizabeth J. Hait & Douglas R. McDonald. (2018) Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders. Clinical Reviews in Allergy & Immunology 57:2, pages 213-225.
Crossref
Crossref
Suprabhat Mukherjee, Nikhilesh Joardar, Subhasree Sengupta & Santi P. Sinha Babu. (2018) Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings. The Journal of Nutritional Biochemistry 61, pages 111-128.
Crossref
Crossref
Suma Sarojini. 2018. Diet, Microbiome and Health. Diet, Microbiome and Health
1
31
.
Daniel Bergemalm, Robert Kruse, Maria Sapnara, Jonas Halfvarson & Elisabeth Hultgren Hörnquist. (2017) Elevated fecal peptidase D at onset of colitis in Galphai2-/- mice, a mouse model of IBD. PLOS ONE 12:3, pages e0174275.
Crossref
Crossref
Dipti V. Tillu, Shayne N. Hassler, Carolina C. Burgos-Vega, Tammie L. Quinn, Robert E. Sorge, Gregory Dussor, Scott Boitano, Josef Vagner & Theodore J. Price. (2015) Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state. Pain 156:5, pages 859-867.
Crossref
Crossref
Meredith A. J. Hullar, Andrea N. Burnett-Hartman & Johanna W. Lampe. 2014. Advances in Nutrition and Cancer. Advances in Nutrition and Cancer
377
399
.
E. S. Michael, A. Kuliopulos, L. Covic, M. L. Steer & G. Perides. (2013) Pharmacological inhibition of PAR2 with the pepducin P2pal-18S protects mice against acute experimental biliary pancreatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 304:5, pages G516-G526.
Crossref
Crossref
Arne Kandulski & Peter Malfertheiner. (2011) Gastroesophageal reflux disease—from reflux episodes to mucosal inflammation. Nature Reviews Gastroenterology & Hepatology 9:1, pages 15-22.
Crossref
Crossref
Scott Boitano, Andrea N. Flynn, Stephanie M. Schulz, Justin Hoffman, Theodore J. Price & Josef Vagner. (2011)
Potent Agonists of the Protease Activated Receptor 2 (PAR
2
)
. Journal of Medicinal Chemistry 54:5, pages 1308-1313.
Crossref
Crossref
Kjetil Søreide. 2011. Handbook of Epigenetics. Handbook of Epigenetics
477
494
.
Rhonda F Souza. (2010) Bringing GERD Management up to PAR-2. American Journal of Gastroenterology 105:9, pages 1944-1946.
Crossref
Crossref
k. n. browning. (2010) Protease-activated receptors: novel central role in modulation of gastric functions. Neurogastroenterology & Motility 22:4, pages 361-365.
Crossref
Crossref
A Gaber, M Johansson, U-H Stenman, K Hotakainen, F Pontén, B Glimelius, A Bjartell, K Jirström & H Birgisson. (2009) High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. British Journal of Cancer 100:10, pages 1540-1548.
Crossref
Crossref
Kjetil Søreide, Bjørn S. Nedrebø, Jens-Christian Knapp, Tom B. Glomsaker, Jon Arne Søreide & Hartwig Kørner. (2009) Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: Potential implications for the surgical oncologist. Surgical Oncology 18:1, pages 31-50.
Crossref
Crossref